Caring for patients with chronic pain: Pearls and pitfalls

Journal of the American Osteopathic Association

Volumn 113, Issue 8, 2013, Pages 620-627

  Debono, David J ^a   Hoeksema, Laura J ^b   Hobbs, Raymond D ^b  

^a Michigan Hematology Oncology   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ANALGESIA; ARTICLE; CHRONIC PAIN; EMOTION; HUMAN; OPIATE ADDICTION; PAIN ASSESSMENT; PATHOPHYSIOLOGY; OPIOID-RELATED DISORDERS; PAIN MEASUREMENT;

ANALGESICS, OPIOID; CHRONIC PAIN; EMOTIONS; HUMANS; OPIOID-RELATED DISORDERS; PAIN MANAGEMENT; PAIN MEASUREMENT;

EID: 84881221385     PISSN: 00986151     EISSN: 19451997     Source Type: Journal    
DOI: 10.7556/jaoa.2013.023     Document Type: Article

References (32)

1. Milton J. Paradise Lost. New York, NY: The Odyssey Press; 1935.
2. Committee on Advancing Pain Research, Care, and Education, Institute of Medicine; Board on Health Sciences Policy. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: The National Academies Press; 2011. http://books.nap.edu/openbook.php?record_id=13172. Accessed November 13, 2012.
3. Matthias MS, Parpart AL, Nyland KA, et al. The patient-provider relationship in chronic pain care: providers' perspectives. Pain Med. 2010;11(11):1688-1697.
4. Upshur CC, Bacigalupe G, Luckmann R. "They don't want anything to do with you": patient views of primary care management of chronic pain. Pain Med. 2010;11(12):1791-1798.
5. Gatchel RJ, Peng YB, Peters ML, Fuchs PN, Turk DC. The biopsychosocial approach to chronic pain: scientific advances and future directions. Psychol Bull. 2007;133(4):581-624.
6. Melzack R. Evolution of the neuromatrix theory of pain: The Prithvi Raj Lecture-presented at the third World Congress of World Institute of Pain, Barcelona 2004. Pain Practice. 2005;5(2):85-94.
7. Dersh J, Gatchel RJ, Mayer T, Polatin P, Temple OR. Prevalence of psychiatric disorders in patients with chronic disabling occupational spinal disorders. Spine (Phila Pa 1976). 2006;31(10):1156-1162.
8. Chou R, Loeser JD, Owens DK, et al. Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: an evidence-based clinical practice guideline from the American Pain Society. Spine (Phila Pa 1976). 2009;34(10):1066-1077.
9. Stanos S. Focused review of interdisciplinary pain rehabilitation programs for chronic pain management. Curr Pain Headache Rep. 2012;16(2):147-152.
10. Chou R, Huffman LH. Nonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med. 2007;147(7):492-504.
11. Clinical Guideline Subcommittee on Low Back Pain. American Osteopathic Association guidelines for osteopathic manipulative treatment (OMT) for patients with low back pain. J Am Osteopath Assoc. 2010;110(11):653-666.
12. Policy impact: prescription painkiller overdoses. US Centers for Disease Control and Prevention website. http://www.cdc.gov/homeandrecreationalsafety/rxbrief. Accessed May 7, 2012.
13. Paulozzi LJ, Jones CM, Mack KA, Rudd RA. Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. MMWR. 2011;60(43):1487-1492.
14. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349(20):1943-1953.
15. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004;112(3):372-380.
16. Rosenblum A, Marsch LA, Joseph H, Portenoy RK. Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol. 2008;16(5):405-416.
17. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113-130.
18. Fine PG, Finnegan T, Portenoy RK. Protect your patients, protect your practice: practical risk assessment in the structuring of opioid therapy in chronic pain. J Fam Pract. 2010;59(9 suppl 2):S1-S16.
19. Kahan M, Mailis-Gagnon A, Wilson L, Srivastava A. Canadian guideline for safe and effective use of opioids for chronic noncancer pain-clinical summary for family physicians, part 1: general population. Can Fam Physician. 2011;57(11):1257-1266.
20. Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain [review]. Cochrane Database Syst Rev. 2010;1:CD006605.
21. Pain (PDQ). National Cancer Institute website. http://cancer.gov/cancertopics/pdq/supportivecare/pain/HealthProfessional. Updated May 3, 2012. Accessed June 11, 2013.
22. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152(2):85-92.
23. Bohnert ASB, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305(13):1315-1321.
24. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300(22):2613-2620.
25. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6(6):432-442.
26. Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? a structured evidence-based review. Pain Med. 2008;9(4):444-459.
27. Kornick CA, Santiago-Palma J, Moryl N, Payne R, Obbens EA. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain. Drug Saf. 2003;26(13):951-973.
28. Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005;6(2):107-112.
29. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med. 2005;6(6):432-442.
30. Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ. Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med. 2010;152(11):712-720.
31. Christo PJ, Manchikanti L, Ruan X, et al. Urine drug testing in chronic pain. Pain Physician. 2011;14(2):123-143.
32. Prescription monitoring frequently asked questions (FAQ). Alliance of States with Prescription Monitoring Programs website. http://www.pmpalliance.org/content/prescription-monitoring-frequently-asked-questions-faq. Accessed March 27, 2012.